Serine proteases and brain damage - is there a link?

Area of Science:

• Neuroscience
• Biochemistry
• Pathology

Background:

• The blood-brain barrier (BBB) regulates molecular traffic between blood and the central nervous system (CNS).
• BBB integrity is crucial for maintaining a healthy neural environment, preventing entry of harmful blood components.
• Pathological conditions like stroke and head trauma can disrupt the BBB.

Purpose of the Study:

• To investigate the effects of blood-derived proteases entering the CNS following BBB disruption.
• To understand the role of these proteases in neuropathological processes.

Main Methods:

• Review of existing evidence on BBB function and disruption.
• Analysis of studies examining the impact of specific blood proteases (thrombin, tPA, plasmin) in CNS injury models.
• Examination of molecular mechanisms linking protease activity to neuronal and glial responses.

Main Results:

• Blood-derived proteases, including serine proteases like thrombin, tissue plasminogen activator (tPA), and plasmin, can access CNS extracellular spaces when the BBB is compromised.
• These proteases are implicated in the cascade of events following cerebrovascular insults.
• Evidence suggests their involvement in glial scarring, edema formation, seizures, and neuronal death.

Conclusions:

• Blood-derived serine proteases play a significant role in the neuropathology following BBB breakdown.
• Understanding these protease activities is crucial for developing therapeutic strategies for CNS injuries.
• Further research is warranted to elucidate the precise mechanisms and therapeutic targets.